lysophosphatidylcholine O-16:0/0:0
Modify Date: 2024-01-09 09:40:28
lysophosphatidylcholine O-16:0/0:0 structure
|
Common Name | lysophosphatidylcholine O-16:0/0:0 | ||
|---|---|---|---|---|
| CAS Number | 52691-62-0 | Molecular Weight | 481.647 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H52NO6P | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of lysophosphatidylcholine O-16:0/0:0Lyso-PAF C-16 is a substrate of lysoplasmalogen (LysoPls)-specific phospholipase D (LysoPLD). Lyso-PAF C-16 selective acetylates with arachidonic acid[1][2]. |
| Name | 1-o-hexadecyl-sn-glycero-3-phosphocholine |
|---|---|
| Synonym | More Synonyms |
| Description | Lyso-PAF C-16 is a substrate of lysoplasmalogen (LysoPls)-specific phospholipase D (LysoPLD). Lyso-PAF C-16 selective acetylates with arachidonic acid[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C24H52NO6P |
|---|---|
| Molecular Weight | 481.647 |
| Exact Mass | 481.353210 |
| PSA | 97.86000 |
| LogP | 3.23 |
| Precursor 0 | |
|---|---|
| DownStream 2 | |
CAS#:74389-68-7
CAS#:88587-94-4| HS Code | 2923900090 |
|---|---|
| Summary | 2923900090 other quaternary ammonium salts and hydroxides。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |
|
Metabolism of platelet-activating factor by rat alveolar macrophages: lyso-PAF as an obligatory intermediate in the formation of alkylarachidonoyl glycerophosphocholine species.
Biochim. Biophys. Acta 837 , 52, (1985) 1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine (alkylacetyl-GPC; platelet-activating factor; PAF) is actively taken up and metabolized by rat alveolar macrophages maintained in culture. The major metabo... |
|
|
Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart.
J. Mol. Cell. Cardiol. 20(6) , 547-61, (1988) Myocardial injury was produced in separated groups of anesthetized rabbits by occlusion of the left circumflex coronary artery for 1 h followed by reperfusion for 2, 4, or 6 h after release of the occ... |
|
|
Metabolism of platelet activating factor (PAF) and related ether lipids by neonatal rat myocytes.
J. Lipid Mediat. 1(2) , 113-23, (1989) Suspensions of neonatal rat myocytes were used to investigate the metabolism of [3H]PAF (1-alkyl-2-acetyl-(sn-glycero-3-phosphocholine) (GPC] and [3H]alkyllyso-GPC. [3H]Alkylacyl-GPC consisting of mol... |
| LYSO-PAF16 |
| Ethanaminium, 2-[[[(2R)-3-(hexadecyloxy)-2-hydroxypropoxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt |
| 1-hexadecyl-sn-glycero-3-phosphocholine |
| 1-hexadecyl |
| 1-O-hexadecyl lyso PAF |
| C16 LYSO PAF |
| 1-O-hexadecyl lyso platelet-activating factor |
| 1-O-PALMITYL-SN-GLYCERO-3-PHOSPHOCHOLINE |
| lysophosphatidylcholine O-16:0/0:0 |
| 1-O-hexadecyl-2-lyso-sn-glycero-3-phosphocholine |
| (2R)-3-(Hexadecyloxy)-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate |
| 1-O-hexadecyl-2-hydroxy-sn-glycero-3-phosphocholine |
| LYSO-PLATELET ACTIVATING FACTOR |
| MFCD00042932 |
| 1-alkyl-2-hydroxy-sn-glycero-3-phosphocholine |
| LYSO-PLATELET ACTIVATING FACTOR-16 |
| 1-Hexyldecyl-sn-glycerol-3-phosphorylcholine |